Pinnacle Wealth Management Advisory Group’s Acumen Pharmaceuticals ABOS Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.5K	Hold	18,020	–	–	﹤0.01%	538
2025 Q4	$38K	Hold	18,020	–	–	﹤0.01%	518
2025 Q3	$30.8K	Hold	18,020	–	–	﹤0.01%	395
2025 Q2	$20.9K	Hold	18,020	–	–	﹤0.01%	366
2025 Q1	$19.8K	Hold	18,020	–	–	﹤0.01%	358
2024 Q4	$31K	Hold	18,020	–	–	﹤0.01%	354
2024 Q3	$44.7K	Hold	18,020	–	–	﹤0.01%	357
2024 Q2	$43.6K	Hold	18,020	–	–	﹤0.01%	346
2024 Q1	$73K	Buy	+18,020	New	+$67.9K	0.01%	342
2023 Q4	–	Sell	-18,020	Closed	-$74.8K	–	339
2023 Q3	$74.8K	Hold	18,020	–	–	0.01%	307
2023 Q2	$86.7K	Buy	+18,020	New	+$86.3K	0.01%	320

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's ABOS Position: Q1 2026 in Review

Pinnacle Wealth Management Advisory Group held its Acumen Pharmaceuticals (ABOS) position steady in Q1 2026 at 18,020 shares worth $42.5K. The position accounts for ﹤0.01% of the portfolio, ranked #538.

Pinnacle Wealth Management Advisory Group first reported a position in ABOS in Q2 2023 and has held it in 11 quarters since. The position peaked at $86.7K in Q2 2023. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

Pinnacle Wealth Management Advisory Group held 18,020 shares of Acumen Pharmaceuticals worth $42.5K as of Q1 2026.
Pinnacle Wealth Management Advisory Group left its Acumen Pharmaceuticals share count unchanged in Q1 2026.
Acumen Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Management Advisory Group's portfolio in Q1 2026, its #538 holding.
Pinnacle Wealth Management Advisory Group first reported a position in Acumen Pharmaceuticals in Q2 2023 and has held it in 11 quarters since.
Pinnacle Wealth Management Advisory Group's Acumen Pharmaceuticals position peaked at $86.7K in Q2 2023.
84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.